Tue.Mar 18, 2025

article thumbnail

Why This Health Plan Moved Away from Exclusive Relationships with Specialty Pharmacies

MedCity News

Several years ago, Highmark began questioning its exclusive relationships with specialty pharmacies and started working with Free Market Health, which matches patients to the pharmacy that best fits their needs. The post Why This Health Plan Moved Away from Exclusive Relationships with Specialty Pharmacies appeared first on MedCity News.

Marketing 262
article thumbnail

How non-traditional investors fuel up-and-coming biotechs when VC funding dries up

PharmaVoice

Smaller biotechs are finding creative ways to fund R&D at a time when the traditional financing channels have become more constrictive.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys

MedCity News

Sarepta Therapeutics said the Duchenne muscular dystrophy patient recently had a cytomegalovirus infection, which can damage the liver and may have contributed to the fatality. Its the first patient death out of more than 800 patients treated with Elevidys, a gene therapy for the rare muscle-wasting disease. The post Liver Failure-Associated Death Reported in Patient Treated With Sarepta Gene Therapy Elevidys appeared first on MedCity News.

Patients 227
article thumbnail

Tips to rise in your career Marketing Pharma

Pharma Marketing Network

Introduction Climbing the ladder in marketing pharma requires more than just technical skills. The pharmaceutical industry is competitive, fast-paced, and highly regulated, making it essential for marketers to stay ahead of trends, build strong industry relationships, and continuously improve their strategic thinking. But how can you stand out in a crowded market?

article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

Reimagining Mental Healthcare: We Need A New Road, Not A Bigger Truck

MedCity News

We need to embrace a more holistic, integrated approach to mental healthcare: one that combines the best of human expertise with rapid innovations of technology, all while being mindful of the real-world challenges faced by marginalized and underserved communities. The post Reimagining Mental Healthcare: We Need A New Road, Not A Bigger Truck appeared first on MedCity News.

More Trending

article thumbnail

Modernizing Fax Systems in Healthcare: A Reliable Foundation for Interoperability

MedCity News

The key to realizing the full potential of legacy systems in modern healthcare lies in overcoming interoperability challenges ensuring seamless data exchange between various systems while preserving the trusted reliability and security healthcare providers depend on. The post Modernizing Fax Systems in Healthcare: A Reliable Foundation for Interoperability appeared first on MedCity News.

article thumbnail

Novo Nordisk industry membership reinstated

European Pharmaceutical Review

Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021. The case was the eighth instance in the past four decades that the ABPIs board has issued this degree of sanction, the industry body highlighted upon announcing the news.

article thumbnail

AstraZeneca and Alteogen agree on ALT-B4 platform tech

Pharmaceutical Technology

AstraZeneca has entered an exclusive licence agreement with Alteogen involving the latters ALT-B4 platform technology.

110
110
article thumbnail

The Digital Determinants of Health: Shaping the Future of Well-Being

Eversana Intouch

In our latest POV by Roberto Ascione, President of EVERSANA INTOUCHs Health Innovation, and Ferdinando Scala, Director of Strategic Planning, the evolving landscape of digital health and its implications for the life sciences industry are explored with an emphasis on the importance of understanding digital determinants of health, which include factors such as internet access, digital literacy, and the availability of digital devices.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Novo Nordisk returns to ABPI fold after two-year suspension

pharmaphorum

Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements"

94
article thumbnail

Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia

Pharmaceutical Technology

Health Canada has granted approval for Biogens Skyclarys to treat Friedreichs ataxia (FA) in individuals aged 16 years and above.

89
article thumbnail

Sofinnova closes new fund and backs a trio of new biotechs

pharmaphorum

Sofinnova Partners has raised 165m for its new biotech fund and backed three startups working on Alzheimer's, fibrotic diseases, and cell therapies

91
article thumbnail

Big tech meets biotech: Recursion and the AI gold rush in pharma 

Pharmaceutical Technology

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, with a notable acceleration in recent years.

Pharma 82
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

UKHSA announces new effort to tackle hepatitis C

PharmaTimes

The agency has launched a whole genome sequencing service to monitor the virus

75
article thumbnail

AstraZeneca buys cell therapy biotech for up to $1bn

pharmaphorum

AstraZeneca plans to acquire Belgian in vivo cell therapy biotech EsoBiotec and has signed a pair of licensing deals with drug delivery firm Alteogen.

62
article thumbnail

Access USA 2025: This Year’s State of the Industry

Pharmaceutical Commerce

The conferences opening session highlights the sectors current landscape of healthcare coverage and access.

article thumbnail

Vertanical's cannabis-based painkiller hits target in trials

pharmaphorum

A cannabis-derived drug developed by Vertanical has shown efficacy in phase 3 for chronic back pain and could reach its first markets soon

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Opko and Entera focus on oral care for obesity and metabolic disorders

Pharmaceutical Technology

Opko Health and Entera Bio have announced a partnership and licence agreement to progress the development of oral dual agonist GLP-1.

59
article thumbnail

EnteroBiotix cues up larger trial of microbiome IBS therapy

pharmaphorum

EnteroBiotix has reported phase 2a proof-of-concept data for its therapy for irritable bowel syndrome (IBS) based on gut microbiome species

58
article thumbnail

Study Explores Effectiveness of HTD1801 in Type 2 Diabetes

Pharmacy Times

Treatment with HTD1801 resulted in significant reductions in the hemoglobin A1c level and improved key cardiometabolic and liver parameters.

52
article thumbnail

DCAT Week 2025: Expanding Sterile Injectables Capacity

PharmaTech

PharmTech Group interviewed Lee Karras of Noramco live on site at DCAT Week 2025, shortly after the company announced a $25 million investment in sterile injectable manufacturing capabilities at its Halo Pharma facility in New Jersey.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

How Pharma Leaders Can Secure Supply Chains

Pharmaceutical Commerce

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDOs national life sciences co-leader, outlines the ways that tariffs disrupt pharma supply chains, along with how leaders can evaluate and prepare for the resulting challenges.

Pharma 52
article thumbnail

DCAT Week 2025: Impact of Geopolitical Climate on Biopharma

PharmaTech

PharmTech sat down with Joseph Principe, chief commercial officer at Abzena ahead of DCAT Week 2025 to get his perspective on how the geopolitical climate is impacting the industry.

article thumbnail

Curevo procures $110m and former-GSK exec for shingles vaccine candidate

Pharmaceutical Technology

GSKs shingles vaccine Shingrix passed $1bn in sales last year as Curevo aims to grasp market share.

Sales 52
article thumbnail

DCAT Week 2025: A Discussion on Aseptic Processing for Sterile Injectable Manufacturing

PharmaTech

Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in sterile injectable pharmaceutical manufacturing.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Pharma Pulse 3/18/25: Causes of the Innovation Gap in Women’s Health, FDA Grants Kerendia Priority Review in Heart Failure & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 52
article thumbnail

DCAT Week 2025: Quality and Compliance for Animal-derived Products

PharmaTech

Pharmaceutical Technology discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry with Roger Viney, chief commercial officer of ICE Pharma.

Pharma 52
article thumbnail

Pharma Pulse 3/18/25: Modernizing Patient Recruitment, OTC Approaches for Managing Menopause Symptoms & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.